Company profile: PolarityTE
1.1 - Company Overview
Company description
- Provider of SkinTE, an investigational product for complex chronic and acute wound treatment that uses a patient's own tissue to regenerate functional skin, and a clinical development program advancing SkinTE through clinical trials to obtain regulatory approval.
Products and services
- SkinTE: An investigational autologous product engineered for complex wounds, utilizing a patient's own tissue to regenerate functional skin
- Cell and Tissue Polarity Platform: A platform-scale system from PolarityTE that induces cell and tissue polarity, creating uniquely functional tissue
- Clinical Development Program: A clinical-stage program advancing SkinTE through clinical trials to obtain regulatory approval for treating chronic and acute wounds
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PolarityTE
RestoreFlow
HQ: United States
Website
- Description: Provider of research into restorative transplantation of donated human tissue for medical treatment, operating in the healthcare industry; incorporated in 2013 and based in Chicago, Illinois.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RestoreFlow company profile →
Cutiss
HQ: Switzerland
Website
- Description: Provider of regenerative medicine and skin tissue engineering solutions, including denovoSkin, a personalized bio-engineered skin graft for permanent treatment of skin defects and injuries; Viticell, a CE-marked cell therapy for vitiligo and dyspigmented burn scars; automated manufacturing of tissue therapies, clinical development programs, and named-patient basis treatment options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cutiss company profile →
Tepha
HQ: United States
Website
- Description: Provider of a new class of absorbable biomaterials for medical devices, developing and commercializing proprietary polyhydroxyalkanoate technology tailored to meet unmet needs across multiple fields and to be used in surgical procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tepha company profile →
Neuroplast
HQ: The Netherlands
Website
- Description: Provider of neuro-regenerative personalized medicine, a promising therapy that needs dedicated uniform standards and regulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuroplast company profile →
NuTech Medical
HQ: United States
Website
- Description: Provider of biologics for the general orthopedic and spine markets, offering anterior cervical plate systems, allograft interbody spacers, thoracolumbar pedicle screw systems, and NuShield Spine, a protective patch used as a barrier interface between the dura and surrounding musculature.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuTech Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PolarityTE
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PolarityTE
2.2 - Growth funds investing in similar companies to PolarityTE
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PolarityTE
4.2 - Public trading comparable groups for PolarityTE
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →